iBio, Inc. - Common Stock (IBIO)
0.7622
-0.0620 (-7.52%)
NASDAQ · Last Trade: Nov 13th, 12:11 AM EST
Detailed Quote
| Previous Close | 0.8242 |
|---|---|
| Open | 0.8300 |
| Bid | 0.7625 |
| Ask | 0.7788 |
| Day's Range | 0.7600 - 0.8321 |
| 52 Week Range | 0.6859 - 3.820 |
| Volume | 300,034 |
| Market Cap | 26.33M |
| PE Ratio (TTM) | -1.622 |
| EPS (TTM) | -0.5 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 569,402 |
Chart
About iBio, Inc. - Common Stock (IBIO)
Ibio Inc is a biotechnology company that focuses on the development and commercialization of innovative biologic therapies for various diseases. Utilizing its proprietary plant-based expression platform, the company aims to create a range of scalable, cost-effective solutions for producing proteins and antibodies that can be used in therapies and vaccines. Ibio also engages in collaborations and partnerships to accelerate the development of its product pipeline and enhance its technology, ultimately striving to improve patient outcomes in areas such as infectious diseases and cancer. Read More